Profil Pengetahuan dan Keyakinan Vaksinasi Covid-19 Aztrazeneca dan Sinovac sebagai Upaya Pencegahan Covid-19 pada Warga Surabaya

Profile of AztraZeneca and Sinovac Covid-19 Vaccination Knowledge and Belief as an Effort to Prevent Covid-19 in Surabaya

Authors

  • Ira Purbosari Universitas PGRI Adi Buana Surabaya Author
  • Muhammad Wahyono Universitas PGRI Adi Buana Surabaya Author

Keywords:

Covid-19, Vaksinasi Covid-19, Astra Zeneca, Sinovac, Knowledge

Abstract

Infeksi penyakit Coronavirus 2019 (Covid-19) telah menjangkiti puluhan juta orang dalam pandemik di seluruh dunia. Penyebab utama dari COVID-19 ini adalah SARS-CoV-2. Pencegahan penularan dilaksanakanvaksinasi COVID-19. Adapun daya serap tentang COVID-19 masih rendah sehingga dilakukan analisis profil pengetahuan dan keyakinan vaksinasi COVID-19 pada masyarakat. Hal utama dari penelitian ini melihathubungan pengetahuan sikap masyarakat terhadap vaksinasi Covid-19. Metode yang dipakai untuk data pengambilan sampel yaitupenelitian observasional analitik dengan metode cross sectionalyaitu dengan responden warga Surabaya sebanyak 380 orang yang dipilih seacara teknik consecutive samplingmelaluipengambilan data kuisioner. Populasi penelitian ini adalah semua warga Surabaya yang telah selesai di vaksinasi tahap I dan tahap II. Pada penelitianmenggunakan lembar pengumpul data untuk mencatat data sekunder lembarkejadian KIPI dari Dinas Kesehatan Kota Surabaya serta menggunakanmetode survei melalui kuisioner yang dibagikan kepada subjek. Analisis data menggunakan analisis statistik uji logistik. Dari hasil penelitian sebanyak sebanyak 77,8 % masyarakat mengetahui vaksin COVID-19, dikategorikan dengan skor sangat baik. Tingginya skor ini menunjukkan tingginya tingkat kepercayaan masyarakat. Sehingga ini terbukti meningginya tingkat keyakinan sebesar 83,1% terbukti responden memiliki sikap positip terhadap suksesnya pengendalianCOVID-19. Penelitian ini menunjukkan sebesar 94,7%adanya hubungan pengetahuan sikap masyarakat terhadap vaksinasi Covid-19, karena itu pengetahuan dan keyakinan perlu dilakukan kepada masyarakat agar niat melakukan vaksinasi COVID-19 meningkat, sehingga akan menekan laju penularan virus.

References

Liu and S. Liu, “The management of coronavirus disease 2019 (COVID-19),” J. Med. Virol., vol. 92, no. 9, pp. 1484–1490, 2020, doi: 10.1002/jmv.25965.

Y. Ophinni et al., “COVID-19 Vaccines: Current Status and Implication for Use in Indonesia,” Acta Med. Indones., vol. 52, no. 4, pp. 388–412, 2020.

W. H. O, “WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020,” WHO Director General’s speeches, no. March. p. 4, 2020, [Online]. Available: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020%0Ahttps://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19.

M. Voysey et al., “Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK,” Lancet, vol. 397, no. 10269, pp. 99–111, 2021, doi: 10.1016/S0140-6736(20)32661-1.

N. C. Pfefferbaum, B., “Engla, Journal - 2010 - New engla nd journal,” N. Engl. J. Med., vol. 6, no. 1, pp. 510–512, 2020, [Online]. Available: nejm.org.

T. Wibawa, “COVID-19 vaccine research and development: ethical issues,” Trop. Med. Int. Heal., vol. 26, no. 1, pp. 14–19, 2021, doi: 10.1111/tmi.13503.

H. Harapan et al., “Willingness-to-pay for a COVID-19 vaccine and its associated determinants in Indonesia,” Hum. Vaccines Immunother., vol. 16, no. 12, pp. 3074–3080, 2020, doi: 10.1080/21645515.2020.1819741.

H. Harapan et al., “Acceptance of a COVID-19 Vaccine in Southeast Asia: A Cross-Sectional Study in Indonesia,” Front. Public Heal., vol. 8, no. July, pp. 1–8, 2020, doi: 10.3389/fpubh.2020.00381.

R. L. Soiza, C. Scicluna, and E. C. Thomson, “Efficacy and safety of COVID-19 vaccines in older people,” Age Ageing, vol. 50, no. 2, pp. 279–283, 2021, doi: 10.1093/ageing/afaa274.

B. M. Prü?, “Current state of the first covid-19 vaccines,” Vaccines, vol. 9, no. 1, pp. 1–12, 2021, doi: 10.3390/vaccines9010030.

M. Sreepadmanabh, A. K. Sahu, and A. Chande, “COVID-19: Advances in diagnostic tools, treatment strategies, and vaccine development,” J. Biosci., vol. 45, no. 1, pp. 1–20, 2020, doi: 10.1007/s12038-020-00114-6.

S. Arikunto, No Title, Rev 2010. Jakarta: Rineka Cipta, 2010.

A. A. Azlan, M. R. Hamzah, T. J. Sern, S. H. Ayub, and E. Mohamad, “Public knowledge, attitudes and practices towards COVID-19: A cross-sectional study in Malaysia,” PLoS One, vol. 15, no. 5, pp. 1–15, 2020, doi: 10.1371/journal.pone.0233668.

N. Ab Malik, R. H. Mohd, and N. B. Abdul Kadir, “Knowledge, Self-Efficacy, and Preventive Behavior of COVID-19 Outbreak Among Community in Malaysia,” Asia-Pacific J. Public Heal., vol. 33, no. 5, pp. 674–675, 2021, doi: 10.1177/10105395211012542.

Downloads

Published

2024-11-14

Issue

Vol. 4 No. 3 (2022): J. Sains Kes.

Section

Articles

How to Cite

[1]
I. Purbosari and M. Wahyono, “Profil Pengetahuan dan Keyakinan Vaksinasi Covid-19 Aztrazeneca dan Sinovac sebagai Upaya Pencegahan Covid-19 pada Warga Surabaya: Profile of AztraZeneca and Sinovac Covid-19 Vaccination Knowledge and Belief as an Effort to Prevent Covid-19 in Surabaya”, J. Sains. Kes, vol. 4, no. 3, pp. 313–319, Nov. 2024, Accessed: Aug. 31, 2025. [Online]. Available: https://jsk.ff.unmul.ac.id/index.php/JSK/article/view/574

Most read articles by the same author(s)

Similar Articles

1-10 of 62

You may also start an advanced similarity search for this article.